CHK1-IN-13
CHK1-IN-13 (Compound 38) is a checkpoint kinase 1 (Chk1) inhibitor with an IC50 of 10-50 nM. CHK1-IN-13 has anticancer activity, and can be used for the research of cancers, such as breast, ovarian and prostate cancer[1].
Product Specifications
CAS Number
2120398-52-7
UNSPSC
12352005
Target
Checkpoint Kinase (Chk)
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
O=C(OCC)NCCCOC1=CC(F)=CC(OC)=C1C2=NNC(NC3=NC=C(C#N)N=C3)=C2
Molecular Formula
C21H22FN7O4
Molecular Weight
455.44
References & Citations
[1]Xiong C, et al. 3,5-disubstituted pyrazoles useful as checkpoint kinase 1 (chk1) inhibitors, and their preparations and applications. WO2017132928A1. 2017-08-10.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Chk1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470178-100 1x 100 µL
CD50 (ICAM-3) (186-2G9), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880460-500 1x 500 µL
CD44 Standard (156-3C11), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041683-100 1x 100 µL
Factor XIIIa (Coagulation Factor XIIIA Chain) (F13A1/1683), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042965-100 1x 100 µL
C1QB / Complement C1q B-Chain (C1QB/2965), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details